NCT05445908 2025-11-17SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast CancerSichuan Kelun Pharmaceutical Research Institute Co., Ltd.Phase 2 Active not recruiting175 enrolled